Ephraim Resources (ASX:EPA) Gross Margin %: 0.00% (As of Dec. 2017)


What is Ephraim Resources Gross Margin %?

Ephraim Resources ASX:EPA Gross Margin % is 0.00% as of Dec. 2017. The stock has 1 warning sign investors should review.

Gross Margin % is calculated as gross profit divided by its revenue. Ephraim Resources's Gross Profit for the six months ended in Dec. 2017 was A$0.00 Mil. Ephraim Resources's Revenue for the six months ended in Dec. 2017 was A$0.00 Mil. Therefore, Ephraim Resources's Gross Margin % for the quarter that ended in Dec. 2017 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Ephraim Resources's Gross Margin % or its related term are showing as below:


ASX:EPA's Gross Margin % is not ranked *
in the Biotechnology industry.
Industry Median: 60.94
* Ranked among companies with meaningful Gross Margin % only.

Ephraim Resources had a gross margin of N/A% for the quarter that ended in Dec. 2017 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Ephraim Resources was 0.00% per year.


Ephraim Resources  (ASX:EPA) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Ephraim Resources had a gross margin of N/A% for the quarter that ended in Dec. 2017 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Ephraim Resources Gross Margin % Related Terms


Ephraim Resources Gross Margin % Historical Data

* Premium members only.

The historical data trend for Ephraim Resources's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ephraim Resources Gross Margin % Chart

Ephraim Resources Annual Data
Trend Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ephraim Resources Semi-Annual Data
Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ephraim Resources Gross Margin % Competitor Comparison

For the Biotechnology subindustry, Ephraim Resources's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ephraim Resources Gross Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ephraim Resources's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Ephraim Resources's Gross Margin % falls into.



Ephraim Resources Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Ephraim Resources's Gross Margin for the fiscal year that ended in Jun. 2018 is calculated as

Gross Margin % (A: Jun. 2018 )=Gross Profit (A: Jun. 2018 ) / Revenue (A: Jun. 2018 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

Ephraim Resources's Gross Margin for the quarter that ended in Dec. 2017 is calculated as


Gross Margin % (Q: Dec. 2017 )=Gross Profit (Q: Dec. 2017 ) / Revenue (Q: Dec. 2017 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 0.00% mean?
Ephraim Resources (ASX:EPA) has a Gross Margin % of 0.00% as of Dec. 2017. Gross margin is the ratio of total gross profit to net sales. View historical data on Ephraim Resources and its competitors.
Is Ephraim Resources' Gross Margin % too high?
Ephraim Resources' current Gross Margin % is 0.00%.
How does Ephraim Resources' Gross Margin % compare to competitors?
Ephraim Resources' Gross Margin % of 0.00% can be compared against companies in the Biotechnology industry. The industry median Gross Margin % is 60.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.94, based on 738 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Ephraim Resources and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ephraim Resources's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ephraim Resources stock overvalued right now?
Ephraim Resources (ASX:EPA) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Ephraim Resources (ASX:EPA), the current Gross Margin % is 0.00% as of Dec. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ephraim Resources Business Description

Address C/- Nexia Perth, 88 William Street, Level 3, Perth, WA, AUS, 6000
Ephraim Resources Ltd is an Australia-based company involved in agricultural biogenetics research and experimentation, licensing and consultancy, with a focus on nipah palm breeding, tissue culture, cultivation and plantation, and producing sugar syrup from nipah palm sap.